AbbVie is entering a new chapter of growth, fueled by its blockbuster immunology drugs and expanding neuroscience business. Investor Kevin Simpson shares why he's optimistic.
Prev Story
Next Story
I just bought this pharma stock for its next generation of blockbuster drugs — and its dividend
1 reads
0 reactions
AbbVie is entering a new chapter of growth, fueled by its blockbuster immunology drugs and expanding neuroscience business. Investor Kevin Simpson shares why he's optimistic.
This story is currently in the Upcoming News queue because it received more dislikes than likes. Vote thumbs up to help promote it back to the Published homepage!
Browse Upcoming Feed
Same Story from Other Publications
Compare how 2 other independent news outlets reported on this story.
Prison security check foils attempt to smuggle drugs into Gaur jail
A routine security check at Gaur Prison has led to the seizure of suspected narcotic tablets hidden in a parcel intended for an inmate serving time in a drug-related case, raising fresh concerns about attempts to smuggle contraband into correctional facilities.
#drugs
Compare →
‘Blockbuster’ history of Alexander the Great wins £50,000 Baillie Gifford prize
Alexander: God, King, Man by Edmund Richardson becomes the first ancient history title to win the prestigious nonfiction award
#blockbuster
Compare →
Related Stories
Business & Economy
The Guardian
•
8h ago
The Next Web (TNW)
•
8h ago
Hamro Patro News
•
10h ago
ABC News Australia
•
1h ago
1 / 1